BlackRock »

Fibrobiologics shares owned by BlackRock

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.6M 919k 4.99
2024-03-31 $143k 13k 10.81

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Fibrobiologics

BlackRock
BlackRock
Geode Capital Management
State Street Corporation
Cascade Financial Partners
Vanguard Group
Northern Trust
Optivise Advisory Services
Requisite Capital Management
Bank of America Corporation
American Institute for Advanced Investment Management
Charles Schwab Investment Management
Advisor Group Holdings
HPM Partners
Bank of New York Mellon

View all funds holding Fibrobiologics